Pelhrimov

Researchers are conducting an observational, non-interventional, multicenter study to prospectively collect, store, and analyze biological samples from patients with conditions including Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma, and MGUS. The study aims to establish a common international infrastructure for gathering standard clinical information at the start and during treatment while uniformly collecting and storing biological samples. The main intervention involves the collection and storage of biological samples from participants. The study does not involve treatment but focuses on creating a biobank that can be used for long-term research purposes, with sample storage planned for up to 30 years. Participants will provide written informed consent and contribute biological samples and clinical data. Researchers will monitor compliance with study requirements and follow-up schedules. The primary outcome is the establishment and maintenance of a biobank over a long-term period, supporting future research and analysis.